navigating the challenges of treatment provision in recurrent/metastatic hnscc
Published 2 years ago • 55 plays • Length 38:21Download video MP4
Download video MP3
Similar videos
-
33:50
immunotherapy for recurrent or metastatic hnscc: what are the practical considerations?
-
34:18
guideline-based treatment of recurrent/metastatic cervical cancer
-
32:52
immunotherapy for early-stage, resectable nsclc: from clinical trial data to guidelines
-
36:45
decoding her2 in nsclc: advances in biomarker testing and targeted therapies
-
39:24
adverse event identification and management in locally advanced/metastatic urothelial carcinoma
-
4:35
a new way of detecting and monitoring cancer by measuring ctdna - dr tasha
-
9:42
us healthcare system explained
-
3:58
what to expect from your pet scan - a guide for new patients
-
12:34
immunotherapy in hnscc series: ep 3 - role of the medical oncologist
-
3:30
key points for treatment of advanced hnscc
-
37:21
key considerations for treatment selection and sequencing in patients with rrmm
-
0:51
expert cautions on use of antibiotics with immunotherapy in melanoma
-
0:54
the challenges of implementing car-t approaches in lymphoma
-
1:38
challenges with a precision medicine-based approach in oncology
-
8:58
practical issues surrounding immunotherapy for hnscc
-
1:00:14
ask the experts | everyday back and neck aches: prevention, coping and managing
-
15:26
diagnosing the 'silent killers': what do i need to know?
-
12:10
navigating healthcare system
-
2:38
checkpoint blockade therapy may sensitise non-hodgkin lymphoma to subsequent therapy
-
4:23
pet scan treatment options & challenges
-
2:00
what instruments should i use in skin cancer surgery wound closure? | dr francis tan